Narcolepsy Management with Dextroamphetamine

Efficacy of Dextroamphetamine for Narcolepsy

Dextroamphetamine is conditionally recommended by the American Academy of Sleep Medicine for the treatment of narcolepsy in adults, with studies demonstrating clinically significant improvements in excessive daytime sleepiness and cataplexy 1, 2, 3
The evidence shows that dextroamphetamine effectively addresses the core symptoms of narcolepsy, though the overall quality of evidence is rated as very low 2
Common adverse effects include sweatiness, edginess, weight loss, loss of appetite, and irritability 3

For sustained-release stimulants like Dexedrine Spansule, it is common practice to combine the long-acting form with an immediate-release preparation to provide flexible dosing and address breakthrough symptoms 4
The morning and noon doses of immediate-release dextroamphetamine can be combined to determine the appropriate Spansule dose, with additional immediate-release medication added as needed for afternoon coverage 4
This combination approach helps smooth out the day-long response by eliminating breakthrough symptoms of narcolepsy 4

Dextroamphetamine is an FDA Schedule II controlled substance with a high potential for abuse and dependence 2, 3
Regular monitoring for adverse effects and signs of tolerance is recommended 4
The clinician should document that symptoms could not be controlled at lower doses if using higher total daily doses 4

Methylphenidate (stimulant) is an alternative FDA-approved medication for narcolepsy 1, 5

Regular follow-up to assess treatment efficacy and adverse effects 4
Monitor for signs of tolerance that might require dose adjustments 4
Watch for common adverse effects including appetite suppression, weight loss, and cardiovascular effects 2, 3
Be alert for prohibitive side effects such as severe insomnia, anorexia, headaches, or significant anxiety/irritability 4